Dr Sally Johnson Professor David Kavanagh Professor John Sayer Dr Edwin Wong Megan Bates et al. | Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort | 2024 |
|
Dr Sally Johnson Dr Edwin Wong
| Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group | 2024 |
|
Dr Sally Johnson Professor David Kavanagh Professor John Sayer Dr Edwin Wong Dr Vicky Brocklebank et al. | Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort | 2024 |
|
Dr Edwin Wong Lee-Ann Naidoo Sarah Winn Dr Patrick Walsh Dr Vicky Brocklebank et al. | The Annual Report of the National Renal Complement Therapeutics Centre 2022/23 | 2024 |
|
Emily Glover Dr Kate Smith-Jackson Dr Vicky Brocklebank Dr Valerie Wilson Dr Patrick Walsh et al. | Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic Syndrome | 2023 |
|
Dr Vicky Brocklebank Dr Patrick Walsh Dr Kate Smith-Jackson Dr Thomas Hallam Professor Kevin Marchbank et al. | Atypical haemolytic uraemic syndrome in the era of terminal complement inhibition- An observational cohort study | 2023 |
|
Dr Edwin Wong Professor David Kavanagh
| Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy | 2023 |
|
Dr Ruyue Sun Dr Long Xie Rebecca Russell Dr Edwin Wong Professor Neil Sheerin et al. | Pre-eclampsia is associated with complement pathway activation in the maternal and fetal circulation, and placental tissue | 2023 |
|
Dr Edwin Wong Sarah Winn Dr Michal Malina Dr Sally Johnson Professor Neil Sheerin et al. | The Annual Report of the National Renal Complement Therapeutics Centre 2021/22 | 2023 |
|
Dr Thomas Hallam Tom Cox Dr Kate Smith-Jackson Dr Vicky Brocklebank April Baral et al. | A novel method for real-time analysis of the complement C3b:FH:FI complex reveals dominant negative CFI variants in Age-related Macular Degeneration | 2022 |
|
Emily Hunter Professor Anthony De Soyza Dr Rachel Agbeko Dr Ken Baker Dr Quentin Campbell Hewson et al. | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial | 2022 |
|
Dr Alison Brown Dr Katrina Wood Dr Edwin Wong
| Paraneoplastic cast nephropathy associated with malignant prolactinoma: A case report and literature review | 2022 |
|
Sarah Dunn Abishek Umashankar Andrew Bryant Dr Sonya Carnell Dr Thomas Chadwick et al. | Saftey and impact of eculizumab withdrawal in patients with atypical haemolytic uraemic syndrome: protocol for a multicentre, open-label, prospective, single-arm study | 2022 |
|
Dr Edwin Wong Thomas Hallam Dr Vicky Brocklebank Dr Patrick Walsh Dr Kate Smith-Jackson et al. | Functional characterisation of rare genetic variants in the N-terminus of complement factor H in aHUS, C3G and AMD | 2021 |
|
Dr Edwin Wong Sarah Winn Dr Michal Malina Dr Sally Johnson Professor Neil Sheerin et al. | The Annual Report of the National Renal Complement Therapeutics Centre 2020/21 | 2021 |
|
Dr Edwin Wong Professor Claire Harris Professor Kevin Marchbank Dr Sally Johnson
| Large scale whole-genome sequencing reveals the genetic architecture of primary membranoproliferative glomerulonephritis and C3 glomerulopathy | 2020 |
|
Dr Vicky Brocklebank Dr Kate Smith-Jackson Dr Patrick Walsh Professor Kevin Marchbank Professor Claire Harris et al. | Long-term outcomes and response to treatment in DGKE nephropathy | 2020 |
|
Dr Edwin Wong Lisa Batchelor Dr Michal Malina Dr Sally Johnson Professor Neil Sheerin et al. | The Annual Report of the National Renal Complement Therapeutics Centre 2019/20 | 2020 |
|
Dr Edwin Wong Jo Stout Jalibani Ndebele Angela Watt Lisa Batchelor et al. | The Annual Report of the National Renal Complement Therapeutics Centre 2018/19 | 2019 |
|
Dr Edwin Wong Professor David Kavanagh
| Diseases of complement dysregulation—an overview | 2018 |
|
Professor Patrick Chinnery Ingrid Emmerson Professor Rita Horvath Dr Sally Johnson Deborah Shipley et al. | Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data | 2018 |
|
Dr Edwin Wong Jo Stout Jalibani Ndebele Angela Watt Dr Michal Malina et al. | The Annual Report of the National Renal Complement Therapeutics Centre 2017/18 | 2018 |
|
Dr Edwin Wong Dr Yi Yang Professor Kevin Marchbank Professor David Kavanagh
| Disease-linked mutations in factor H reveal pivotal role of cofactor activity in self surface-selective regulation of complement activation | 2017 |
|
Dr Vicky Brocklebank Dr Sally Johnson Dr Patrick Walsh Dr Edwin Wong Dr Larissa Kerecuk et al. | Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland | 2017 |
|
Professor David Kavanagh Dr Edwin Wong Dr Vicky Brocklebank
| Hemolytic Uremic Syndrome in Pregnancy and Post-Partum | 2017 |
|
Dr Edwin Wong Dr Sally Johnson Professor Neil Sheerin Professor David Kavanagh
| The Annual Report of the National Renal Complement Therapeutics Centre 2016/2017 | 2017 |
|
Rachel Challis Dr Edwin Wong Dr Vicky Brocklebank Dr Valerie Wilson Professor Kevin Marchbank et al. | Thrombotic Microangiopathy in Inverted Formin 2-Mediated Renal Disease | 2017 |
|
Rachel Challis Dr Edwin Wong Dr Holly Anderson Dr Valerie Wilson Dr Vicky Brocklebank et al. | A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H–Related 3 Gene in Atypical Hemolytic Uremic Syndrome | 2016 |
|
Dr Vicky Brocklebank Dr Edwin Wong Professor Kevin Marchbank Professor Tim Goodship Professor David Kavanagh et al. | The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies | 2016 |
|
Dr Isabel Pappworth Dr Edwin Wong Professor Neil Sheerin Professor Kevin Marchbank
| An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy | 2015 |
|
Dr Edwin Wong Professor David Kavanagh
| Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome | 2015 |
|
Dr Edwin Wong Dr Vicky Brocklebank Professor Tim Goodship Professor David Kavanagh Dr Anna Richards et al. | Characterisation of a C3 Mutation with Increased Resistance to Complement Regulation in an Individual with Recurrent C3GN in a Renel Transplant | 2015 |
|
Dr Edwin Wong Dr Jeremy Palmer Professor Neil Sheerin Dr Isabel Pappworth
| FH1-5(18-20) ameliorates experimental C3 glomerulopathy; generation and testing of a murine version for further pre-clinical experiments | 2015 |
|
Dr Edwin Wong Rachel Challis Professor Neil Sheerin Dr Sally Johnson Professor David Kavanagh et al. | Patient stratification and therapy in atypical haemolytic uraemic syndrome (aHUS) | 2015 |
|
Dr Edwin Wong Dr Isabel Pappworth Professor Claire Harris Professor Tim Goodship Dr Sally Johnson et al. | The national study of membranoproliferative glomerulonephrtis and C3 glomerulopathy - characterisation of the paediatric cohort | 2015 |
|
Dr Vicky Brocklebank Dr Edwin Wong Professor Tim Goodship Professor David Kavanagh
| Atypical haemolytic uraemic syndrome associated with a CD46 mutation triggered by Shigella flexneri | 2014 |
|
Dr Edwin Wong Dr Holly Anderson Rachel Challis Dr Lisa Turnbull Gladys - et al. | Characterization of a Factor H Mutation That Perturbs the Alternative Pathway of Complement in a Family with Membranoproliferative GN | 2014 |
|
Dr Sally Johnson Dr Edwin Wong
| Making sense of the spectrum of glomerular disease associated with complement dysregulation | 2014 |
|
Dr Edwin Wong Professor John Sayer
| Sarcoidosis presenting with hypercalcaemia following withdrawal of long-term immunosuppression in renal transplantation | 2014 |
|
Dr Edwin Wong Professor David Kavanagh
| Whole-exome sequencing identifies rare, functional CFH variants in families with macular degeneration | 2014 |
|
Rachel Challis Dr Holly Anderson Dr Edwin Wong Dr Lisa Turnbull Professor Kevin Marchbank et al. | Atypical haemolytic uraemic syndrome associated with a novel hybrid CFH/CFHR3 gene | 2013 |
|
Dr Edwin Wong Professor Tim Goodship Professor David Kavanagh
| Complement therapy in atypical haemolytic uraemic syndrome (aHUS) | 2013 |
|
Dr Edwin Wong Mark Brady Professor Neil Sheerin
| Severe intestinal oedema due to nephrotic syndrome | 2013 |
|
Dr Edwin Wong Dr Holly Anderson Rachel Challis Professor Kevin Marchbank Professor David Kavanagh et al. | Familial membranoproliferative glomerulonephritis type I associated with a functionally significant mutation in complement factor H | 2012 |
|
Dr Edwin Wong
| Successful management of bilateral emphysematous pyelonephritis in end-stage polycystic kidneys: bilateral native nephrectomies and preservation of functioning renal transplant | 2011 |
|